Skip to main content

Advertisement

Log in

Is there a Role for MRI in the Preoperative Assessment of Patients with DCIS?

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Breast magnetic resonance imaging (MRI) is used to identify residual and additional disease in patients with invasive carcinoma. The use of MRI in assessing extent of disease for ductal carcinoma in situ (DCIS) is less well defined. This study assessed the value of MRI in the preoperative evaluation of DCIS.

Materials and Methods

We identified 98 patients with DCIS in 2007. Of these, 63 underwent stereotactic biopsy, followed by MRI. There were 35 who underwent stereotactic biopsy alone. Concordance between MRI and histopathology was defined as the presence or absence of residual disease.

Results

There was no significant difference in mastectomy rates between the MRI and non-MRI group (20.3% vs 25.7%, P = .62). In patients undergoing breast-conserving surgery (BCS), there were fewer positive margins in the MRI versus the non-MRI group (21.2% vs 30.8%, P = .41). Of the 64 cases that underwent preoperative MRI, 43 (67.2%) were concordant. Also, 15 of 43 cases (34.8%) had MRI results that accurately predicted pathologic size. In 28 of 43 patients (65.2%), MRI overestimated disease in 20, by a mean of 1.97 cm. In patients with MRI tumor size >2 cm, MRI overestimated disease by a mean of 3.17 cm. Of the 64 cases, 21 (32.8%) were discordant. Also, 10 of 21 (47.6%) had a positive MRI and no residual disease on histopathology, and 11 of 21 (52.3%) had negative MRI and residual disease on pathology.

Conclusions

MRI does not accurately predict extent of disease in patients with extensive DCIS. In patients with MRI tumor size ≤2 cm, MRI may assist in surgical planning. MRI results in patients with DCIS should be interpreted with caution; decision for mastectomy should not be made on MRI findings alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Swallow CJ, Van Zee KJ, Sacchini V, Borgen PI. Ductal carcinoma in situ of the breast: progress and controversy. Curr Probl Surg. 1996;33:553–608.

    Article  CAS  PubMed  Google Scholar 

  2. Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 1998;16:441–52.

    CAS  PubMed  Google Scholar 

  3. Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1-2 breast carcinomas: implications for clinical trials of breast conserving surgery. Cancer. 1985;56:979–90.

    Article  CAS  PubMed  Google Scholar 

  4. Bleicher RJ, Morrow M. MRI and breast cancer: role in detection, diagnosis, and staging. Oncology (Williston Park). 2007;21:1521–8.

    Google Scholar 

  5. Menell JH, Morris EA, Dershaw DD, Abramson AF, Brogi E, Liberman L. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J. 2005:11;382–90.

    Article  PubMed  Google Scholar 

  6. Hwang ES, Kinkel K, Esserman LJ, Lu Y, Weidner N, Hylton NM. Magnetic resonance imaging in patients diagnosed with ductal carcinoma in situ: value in the diagnosis of residual disease, occult invasion, and multicentricity. Ann Surg Oncol. 2003;10:381–8.

    Article  PubMed  Google Scholar 

  7. Hansen NM, Growney A. Breast cancer: pre- and postoperative imaging for staging. Surg Oncol Clin N Am. 2007;16:447–63.

    Article  PubMed  Google Scholar 

  8. Gilles R, Zafrani B, Guinebretiere JM, Meunier M, Lucidarme O, Tardivon AA, et al. Ductal carcinoma in situ: MR imaging-histopathologic correlation. Radiology. 1995;196:415–9.

    CAS  PubMed  Google Scholar 

  9. Sardanelli F, Giuseppetti GM, Panizza P, Bazzocchi M, Fausto A, Simonetti G, et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J. Roentgenol. 2004;183:1149–57.

    PubMed  Google Scholar 

  10. Harms SE, Flamig DP, Hesley KL, Meiches MD, Jensen RA, Evans WP, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology. 1993;187:493–501.

    CAS  PubMed  Google Scholar 

  11. Bazzocchi M, Zuiani C, Panizza P, Del Frate C, Soldano F, Isola M, et al. Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of a multicenter trial. AJR Am J Roentgenol. 2006;186:1723–32.

    Article  PubMed  Google Scholar 

  12. Schouten van der Velden AP, Boetes C, Bult P, Wobbes T. The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. Am J Surg. 2006;192:172–8.

    Article  PubMed  Google Scholar 

  13. Katipamula R, Degnim AC, Hoskin TL, Boughey JC, Loprinzi C, Grant CS, et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative MRI. J Clin Oncol. 2009;27:4082–8.

    Article  PubMed  Google Scholar 

  14. Bleicher RJ, Ciocca RM, Egleston BL, Sesa L, Evers K, Sigurdson ER, et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg. 2009;209:180–7.

    Article  PubMed  Google Scholar 

  15. Sardanelli F, Bacigalupo L, Carbonaro L, Esseridou A, Giuseppetti GM, Panizza P, et al. What is the sensitivity of mammography and dynamic MR imaging for DCIS if the whole-breast histopathology is used as a reference standard? Radiol Med. 2008;113:439–51.

    Article  CAS  PubMed  Google Scholar 

  16. Onesti JK, Mangus BE, Helmer SD, Osland JS. Breast Cancer Tumor Size: Correlation between magnetic resonance imaging and pathology measurements. Am J Surg. 2008;196:844–50.

    Article  PubMed  Google Scholar 

  17. Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, et al. Diagnostic accuracy of mammography. Clinical examination, US, and MR Imaging of preoperative assessment of breast cancer. Radiology. 2004;233:830–49.

    Article  PubMed  Google Scholar 

  18. Orel SG, Mendonca MH, Reynolds C, Schnall MD, Solin LJ, Sullivan DC. MR Imaging of ductal carcinoma in situ. Radiology. 1997;202:413–20.

    CAS  PubMed  Google Scholar 

  19. Kuhl CK. Review article: MRI of breast tumors. Eur Radiol. 2000;10:46–58.

    Article  CAS  PubMed  Google Scholar 

  20. Morris E, Liberman L. Breast MRI: diagnosis and intervention. New York: Springer Science and Business Media; 2005.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lisa R. Allen MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Allen, L.R., Lago-Toro, C.E., Hughes, J.H. et al. Is there a Role for MRI in the Preoperative Assessment of Patients with DCIS?. Ann Surg Oncol 17, 2395–2400 (2010). https://doi.org/10.1245/s10434-010-1000-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-1000-9

Keywords

Navigation